Eric Nelson is a pharmaceutical scientist with extensive experience in leading overall CMC development efforts. They served as an Associate Director at Johnson and Johnson from 2006 to 2012 and later held roles at Genentech from 2018 to 2024 as a Product Strategy Leader and Senior CMC Team Leader, focusing on oncology products. Currently, Eric is the Executive Director and CMC team leader at Gilead Sciences, while also pursuing a PhD in Analytical Chemistry at Purdue University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices